Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing Type
4
Filing Date
9/4/2024
Updated
9/5/24, 9:50 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership